Full text
PDFPage 1190
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bajusz S., Csernus V. J., Janaky T., Bokser L., Fekete M., Schally A. V. New antagonists of LHRH. II. Inhibition and potentiation of LHRH by closely related analogues. Int J Pept Protein Res. 1988 Dec;32(6):425–435. doi: 10.1111/j.1399-3011.1988.tb01373.x. [DOI] [PubMed] [Google Scholar]
- Buchanan R. B., Blamey R. W., Durrant K. R., Howell A., Paterson A. G., Preece P. E., Smith D. C., Williams C. J., Wilson R. G. A randomized comparison of tamoxifen with surgical oophorectomy in premenopausal patients with advanced breast cancer. J Clin Oncol. 1986 Sep;4(9):1326–1330. doi: 10.1200/JCO.1986.4.9.1326. [DOI] [PubMed] [Google Scholar]
- Fornander T., Rutqvist L. E., Cedermark B., Glas U., Mattsson A., Silfverswärd C., Skoog L., Somell A., Theve T., Wilking N. Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers. Lancet. 1989 Jan 21;1(8630):117–120. doi: 10.1016/s0140-6736(89)91141-0. [DOI] [PubMed] [Google Scholar]
- Hartley J. W., Wong J., Fletcher W. S. Response of advanced breast cancer to total endocrine ablation after exacerbation on tamoxifen: results in seven patients and possible mechanism of action. J Surg Oncol. 1987 Mar;34(3):182–187. doi: 10.1002/jso.2930340311. [DOI] [PubMed] [Google Scholar]
- Ingle J. N., Krook J. E., Green S. J., Kubista T. P., Everson L. K., Ahmann D. L., Chang M. N., Bisel H. F., Windschitl H. E., Twito D. I. Randomized trial of bilateral oophorectomy versus tamoxifen in premenopausal women with metastatic breast cancer. J Clin Oncol. 1986 Feb;4(2):178–185. doi: 10.1200/JCO.1986.4.2.178. [DOI] [PubMed] [Google Scholar]
- Rose C., Mouridsen H. T. Endocrine therapy of advanced breast cancer. Acta Oncol. 1988;27(6A):721–728. doi: 10.3109/02841868809091775. [DOI] [PubMed] [Google Scholar]
- Sharoni Y., Bosin E., Miinster A., Levy J., Schally A. V. Inhibition of growth of human mammary tumor cells by potent antagonists of luteinizing hormone-releasing hormone. Proc Natl Acad Sci U S A. 1989 Mar;86(5):1648–1651. doi: 10.1073/pnas.86.5.1648. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Smith I. E. LHRH analogues in breast cancer: clever, but do we need them? Br J Cancer. 1991 Jan;63(1):15–16. doi: 10.1038/bjc.1991.6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Szende B., Srkalovic G., Groot K., Lapis K., Schally A. V. Growth inhibition of mouse MXT mammary tumor by the luteinizing hormone-releasing hormone antagonist SB-75. J Natl Cancer Inst. 1990 Mar 21;82(6):513–517. doi: 10.1093/jnci/82.6.513. [DOI] [PubMed] [Google Scholar]